Delisting of securities of tuscan holdings corp. ii; clovis oncology, inc.; zyversa therapeutics, inc.; otonomy, inc., and forward pharma a/s from the nasdaq stock market

New york, dec. 28, 2022 (globe newswire) -- the nasdaq stock market announced today that it will delist the common stock, unit, and warrant of tuscan holdings corp. ii. tuscan holdings corp. ii's securities were suspended on november 21, 2022, and have not traded on nasdaq since that time.

NDAQ Ratings Summary

NDAQ Quant Ranking